摘要
目的:探讨大肠埃希菌的临床分布及其耐药性。方法:选取2016年1月-2019年12月本院从住院患者标本中分离的大肠埃希菌673株,对所有病原菌完成临床分布调查,并对其进行药敏试验,检测病原菌的耐药情况。结果:673株大肠埃希菌的主要来源为痰液342株(50.82%),其次是尿液234株(34.77%),其他来源所占比例较小;673株大肠埃希菌分布科室相对较广,外科、ICU、内科系统多药耐药菌株检出率分别为9.50%、10.41%、4.35%。结论:本院大肠埃希菌的主要来源为痰液、尿液,分布科室相对较广,多药耐药菌株检出率较高,应在医院加强耐药菌的监测及病原菌耐药性分析,有效预防感染,提高抗菌药物合理性。
Objective:To investigate the clinical distribution and drug resistance of Escherichia coli.Method:From January 2016 to December 2019,673 strains of Escherichia coli isolated from inpatient samples were selected.The clinical distribution of all pathogens were investigated,and drug sensitivity test was carried out to detect the drug resistance of pathogens.Result:The main source of 673 strains of Escherichia coli was sputum 342(50.82%),followed by urine 234(34.77%),and other sources accounted for a small proportion.673 strains of Escherichia coli were distributed in a wide range of departments,the detection rates of multidrug resistant strains in surgical,ICU and medical systems were 9.50%,10.41%and 4.35%,respectively.Conclusion:The main sources of Escherichia coli in our hospital are sputum and urine,the distribution of departments is relatively wide,and the detection rate of multidrug-resistant strains is relatively high.We should strengthen the monitoring of drug-resistant bacteria and the analysis of drug resistance of pathogenic bacteria in our hospital to effectively prevent infection and improve the rationality of antibiotics.
作者
雷文珍
LEI Wenzhen(Ruizhou Hospital of Gao’an City,Gao’an 330800,China)
出处
《中国医学创新》
CAS
2020年第5期69-72,共4页
Medical Innovation of China
关键词
大肠埃希菌
抗菌药物
耐药性
Escherichia coli
Antibacterial drugs
Drug resistance
